P15358 (ANTA_HAEOF) Reviewed, UniProtKB/Swiss-Prot
Last modified
November 16, 2011.
Version 83.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Antistasin Short name=ATS Alternative name(s): Blood coagulation factor Xa/proclotting enzyme inhibitor |
| Organism | Haementeria officinalis (Mexican leech) |
| Taxonomic identifier | 6410 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Annelida › Clitellata › Hirudinida › Hirudinea › Rhynchobdellida › Glossiphoniidae › Haementeria |
Protein attributes
| Sequence length | 136 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | This highly disulfide-bonded protein is a potent inhibitor of factor Xa. May have therapeutic utility as an anticoagulant. Also exhibits a strong metastatic activity. |
| Subcellular location | |
| Miscellaneous | Binds to heparin-agarose, binds to sulfated glycoconjugates. At least four isoforms of antistasin have been identified in leech salivary gland extracts, which differ by 1 or 2 amino-acid residues. |
| Sequence similarities | Belongs to the protease inhibitor I15 (antistasin) family. [View classification] Contains 2 antistasin-like domains. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Blood coagulation |
| Cellular component | Secreted |
| Domain | Repeat Signal |
| Ligand | Heparin-binding |
| Molecular function | Protease inhibitor Serine protease inhibitor |
| PTM | Disulfide bond Pyrrolidone carboxylic acid |
| Technical term | 3D-structure Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | blood coagulation Inferred from electronic annotation. Source: UniProtKB-KW negative regulation of coagulationInferred from electronic annotation. Source: InterPro |
| Cellular component | extracellular region Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | heparin binding Inferred from electronic annotation. Source: UniProtKB-KW serine-type endopeptidase inhibitor activityInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 17 | 17 | Ref.2 Ref.3 | |||||||||||||||||||||||||
| Chain | 18 – 136 | 119 | Antistasin | PRO_0000001700 | ||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||
| Domain | 45 – 70 | 26 | Antistasin-like 1 | |||||||||||||||||||||||||
| Domain | 100 – 125 | 26 | Antistasin-like 2 | |||||||||||||||||||||||||
| Region | 114 – 117 | 4 | Heparin-binding Potential | |||||||||||||||||||||||||
| Region | 128 – 135 | 8 | Heparin-binding Potential | |||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||
| Site | 51 – 52 | 2 | Reactive bond | |||||||||||||||||||||||||
| Site | 106 – 107 | 2 | Reactive bond | |||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||
| Modified residue | 18 | 1 | Pyrrolidone carboxylic acid | |||||||||||||||||||||||||
| Disulfide bond | 25 ↔ 36 | |||||||||||||||||||||||||||
| Disulfide bond | 30 ↔ 43 | |||||||||||||||||||||||||||
| Disulfide bond | 45 ↔ 65 | |||||||||||||||||||||||||||
| Disulfide bond | 50 ↔ 68 | |||||||||||||||||||||||||||
| Disulfide bond | 54 ↔ 70 | |||||||||||||||||||||||||||
| Disulfide bond | 79 ↔ 90 | |||||||||||||||||||||||||||
| Disulfide bond | 84 ↔ 97 | |||||||||||||||||||||||||||
| Disulfide bond | 99 ↔ 120 | |||||||||||||||||||||||||||
| Disulfide bond | 105 ↔ 123 | |||||||||||||||||||||||||||
| Disulfide bond | 109 ↔ 125 | |||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||
| Natural variant | 22 | 1 | G → R in isoform B. | |||||||||||||||||||||||||
| Natural variant | 47 | 1 | G → E. | |||||||||||||||||||||||||
| Natural variant | 52 | 1 | M → V. | |||||||||||||||||||||||||
| Natural variant | 71 | 1 | R → I. | |||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||
| Helix | 25 – 28 | 4 | ||||||||||||||||||||||||||
| Turn | 38 – 40 | 3 | ||||||||||||||||||||||||||
| Beta strand | 58 – 60 | 3 | ||||||||||||||||||||||||||
| Beta strand | 66 – 70 | 5 | ||||||||||||||||||||||||||
| Helix | 81 – 83 | 3 | ||||||||||||||||||||||||||
| Turn | 92 – 94 | 3 | ||||||||||||||||||||||||||
| Beta strand | 95 – 97 | 3 | ||||||||||||||||||||||||||
| Beta strand | 99 – 101 | 3 | ||||||||||||||||||||||||||
| Beta strand | 113 – 115 | 3 | ||||||||||||||||||||||||||
| Beta strand | 121 – 125 | 5 | ||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Cloning and expression of cDNA encoding antistasin, a leech-derived protein having anti-coagulant and anti-metastatic properties." Han J.H., Law S.W., Keller P.M., Kniskern P.J., Silberklang M., Tung J.S., Gasic T.B., Gasic G.J., Friedman P.A., Ellis R.W. Gene 75:47-57(1989) [PubMed: 2470652] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure." Nutt E., Gasic T., Rodkey J., Gasic G.J., Jacobs J.W., Friedman P.A., Simpson E. J. Biol. Chem. 263:10162-10167(1988) [PubMed: 3164720] [Abstract] Cited for: PROTEIN SEQUENCE OF 18-136. Tissue: Saliva. |
| [3] | "Purification and characterization of inhibitors of blood coagulation factor Xa from hematophagous organisms." Dunwiddie C.T., Waxman L., Vlasuk G.P., Friedman P.A. Methods Enzymol. 223:291-312(1993) [PubMed: 8271959] [Abstract] Cited for: PROTEIN SEQUENCE OF 18-136. Tissue: Saliva. |
| [4] | "Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site." Dunwiddie C., Thornberry N.A., Bull H.G., Sardana M., Friedman P.A., Jacobs J.W., Simpson E. J. Biol. Chem. 264:16694-16699(1989) [PubMed: 2777803] [Abstract] Cited for: REACTIVE SITE. |
| [5] | "Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates." Holt G.D., Krivan H.C., Gasic G.J., Ginsburg V. J. Biol. Chem. 264:12138-12140(1989) [PubMed: 2745433] [Abstract] Cited for: SULFATIDE-BINDING. |
| [6] | "Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive site." Hofmann K.J., Nutt E.M., Dunwiddie C. Biochem. J. 287:943-949(1992) [PubMed: 1445252] [Abstract] Cited for: MUTAGENESIS. |
| [7] | "Mutational analysis of antistasin, an inhibitor of blood coagulation factor Xa derived from the Mexican leech Haementeria officinalis." Theunissen H.J., Dijkema R., Swinkels J.C., de Poorter T.L., Vink P.M., van Dinther T.G. Thromb. Res. 75:41-50(1994) [PubMed: 8073407] [Abstract] Cited for: MUTAGENESIS. |
| [8] | "X-ray structure of antistasin at 1.9-A resolution and its modelled complex with blood coagulation factor Xa." Lapatto R., Krengel U., Schreuder H.A., Arkema A., de Boer B., Kalk K.H., Hol W.G.J., Grootenhuis P.D.J., Mulders J.W.M., Dijkema R., Theunissen H.J.M., Dijkstra B.W. EMBO J. 16:5151-5161(1997) [PubMed: 9311976] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 24-127. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M24422 mRNA. Translation: AAA29192.1. M24423 mRNA. Translation: AAA29193.1. | ||||||||||||
| PIR | A28806. A34398. JS0209. S13904. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P15358. | ||||||||||||
| SMR | P15358. Positions 24-127. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein family/group databases | |||||||||||||
| MEROPS | I15.007. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR011061. Prot_inh_I14/15_hirudin/antisn. IPR018112. Prot_inh_I15_antistasin. IPR004094. Prot_inh_I15_antistasin-like. IPR008086. Prot_inh_I15_antistasin_leech. [Graphical view] | ||||||||||||
| Gene3D | G3DSA:2.10.22.10. Prot_inh_antistn. 2 hits. | ||||||||||||
| Pfam | PF02822. Antistasin. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR01706. ANTISTASIN. | ||||||||||||
| SUPFAM | SSF57262. Antihaemostatic. 2 hits. | ||||||||||||
| PROSITE | PS51252. ANTISTASIN. 2 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Entry information
| Entry name | ANTA_HAEOF | ||||||||
| Accession | Primary (citable) accession number: P15358 Secondary accession number(s): Q9TWQ8, Q9TX45 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with